News

A priority designation accelerates review of the drug and is often given to a drug that, if approved, would be a significant improvement compared with existing treatments. The

The trial is being conducted in seven centers throughout Sweden and will focus on exploring the safety and tolerability of PBT2. The phase IIa study will also examine

The Mylan brand of finasteride, a generic version of Merck’s Proscar, is approved for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate to

Necrotizing enterocolitis (NEC) is a medical condition primarily seen in premature infants, where portions of the bowel undergo tissue death. “Orphan drug status provides TTI-1612 with up to

The total potential value of the agreement was much greater than expected and is the largest ever secured by a biotech company, including the $2 billion deal between

GenVec believes the data may allow the company to implement modifications to the study that could potentially accelerate its conclusion and allow an earlier review by the FDA

HIV-associated lipodystrophy is characterized by major physical changes as well as lipid and carbohydrate disorders, conditions that can foster cardiovascular disease and type 2 diabetes. Patient discomfort with

The decision was taken following a significant imbalance in fluid retention in patients in the study. Speedel commented that fluid retention is not unusual in patients who have

The global trial program for isavuconazole focuses on patients with invasive candidiasis including candidemia and patients with aspergillosis. The program targets two very significant patient groups with high